Advancements in Complex Regional Pain Syndrome
If incorrectly healed, common musculoskeletal injuries to the arms and legs can sometimes develop a chronic pain condition called Complex Regional Pain Syndrome (CRPS). The symptoms vary in intensity and in some rare cases, the pain can start without trauma. To make things worse, there are no FDA-approved medications to successfully manage the condition. However, a new medication is being evaluated that has shown promise in previous research to be well tolerated and potentially effective at reducing the pain associated with CRPS.
• Disproportionate Pain compared in Injury
• Limb Swelling
• Changes in skin Temperature, Color, or Texture
The investigational medication, neridronic acid (NERIXIA®), has been studied in patients with various diseases and was recently approved in Italy for the treatment of CRPS. Treatment is administered 4 times over the course of 10 days and patients will be closely followed for 12 weeks.
All research volunteers may continue their current pain treatment program. The study medication will be added as an additional medication to help further reduce a patient’s pain level.
HOW WE CAN HELP
The Northwest Clinical Research Center has the opportunity to investigate this exciting new therapy. However, we need volunteers willing to participate and complete the research to prove that these new types of treatments help reduce the pain from CRPS. Complete the questionnaire or call our office at (425) 453-0404 to learn more details about the study and to determine if setting up an appointment is good for you.
All study participants receive the following at no cost:
• Clinical Evaluations
• Study Medication
• Medical Care